Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes

Despite modern therapeutic advances, the survival prospects of pancreatic cancer patients have remained poor. Besides being highly metastatic, pancreatic cancer is challenging to treat because it is caused by a heterogeneous array of somatic mutations that impact a variety of signaling pathways and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinkala, Musalula, Mulder, Nicola, Martin, Darren Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044387/
https://www.ncbi.nlm.nih.gov/pubmed/30018740
http://dx.doi.org/10.18632/oncotarget.25632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044387/
https://www.ncbi.nlm.nih.gov/pubmed/30018740
http://dx.doi.org/10.18632/oncotarget.25632

Ejemplares similares